Accepted Manuscript Evaluation of cancer cell deformability by microcavity array Tomoko Yoshino, Tsuyoshi Tanaka, Seita Nakamura, Ryo Negishi, Nozomi Shionoiri, Masahito Hosokawa, Tadashi Matsunaga PII:
S0003-2697(16)30440-7
DOI:
10.1016/j.ab.2016.12.026
Reference:
YABIO 12593
To appear in:
Analytical Biochemistry
Received Date: 12 September 2016 Revised Date:
14 December 2016
Accepted Date: 31 December 2016
Please cite this article as: T. Yoshino, T. Tanaka, S. Nakamura, R. Negishi, N. Shionoiri, M. Hosokawa, T. Matsunaga, Evaluation of cancer cell deformability by microcavity array, Analytical Biochemistry (2017), doi: 10.1016/j.ab.2016.12.026. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
RI PT
ACCEPTED MANUSCRIPT
Evaluation of cancer cell deformability by microcavity array
SC
Tomoko Yoshino,a† Tsuyoshi Tanaka,a Seita Nakamura,a Ryo Negishi,a Nozomi
M AN U
Shionoiri,a Masahito Hosokawa,a and Tadashi Matsunagaa
a. Division of Biotechnology and Life science, Institute of Engineering, Tokyo
184-8588, Japan.
TE D
University of Agriculture and Technology, 2-24-16, Naka-cho, Koganei, Tokyo,
AC C
EP
† Corresponding author.
Phone: +81-42-388-7021 Fax: +81-42-385-7713
e-mail:
[email protected]
ACCEPTED MANUSCRIPT
Abstract
RI PT
A cell entrapment device consisting of a microcavity array was used to analyze the deformability of MCF-10 human breast epithelial and MCF-7 human breast cancer cell lines by confocal laser scanning microscopy. Entrapment of up to 8 × 103 cells was
SC
achieved within 3 min. Protrusions were formed at the bottom surface of the array with
M AN U
a pore size of 3 µm. Protrusion length increased at higher filtration pressures and could be used to distinguish between MCF-7 and MCF-10 cells. These results indicate that our system is useful for high-throughput deformability analysis of cancer cells, which
AC C
EP
TE D
can provide insight into the mechanisms underlying tumor cell malignancy.
Keywords: Cell deformability, Breast cancer
ACCEPTED MANUSCRIPT Introduction
2
Metastasis is a defining feature of cancer that involves the spread of tumor cells from a
3
primary site to secondary tissues or organs. Malignant tumor cells exhibit increased
4
deformability, making them highly invasive and metastatic [1-3]. Therefore, in addition to
5
detecting cancer-specific markers, evaluating the stiffness/deformability of tumor cells could
6
provide information on the mechanistic basis of metastasis.
7
The deformability of cells can be estimated by evaluating their elastic and viscous properties
8
using approaches such as micropipette aspiration, atomic force microscopy, and optical
9
tweezers, among others [4-6]. Recently, microfluidics has been used to increase throughput in
10
cell deformability analyses. Micropipette aspiration, which induces the formation of a
11
hemispherical cell projection by applying negative pressure, has been integrated into
12
microfluidic devices for this purpose. Microchannels are used to estimate cell stiffness by
13
measuring migration time, buoyant mass, and the entry velocity of single cells into a
14
microchannel
15
cell-trapping/aspiration chambers has been proposed that would allow high-throughput
16
measurement of cortical tension and Young’s modulus in single cells to enable an estimation
17
of cell deformability [9]. Cancer cell metastasis can also be studied by genetic approaches
18
including single-cell transcriptome analyses; however, these are limited by the difficulty in
19
isolating target cells from microfluidic devices.
20
We previously developed a microfluidic device consisting of a microcavity array for
21
recovering cancer cells from whole blood based on differences in cell size and deformability
22
[10-12]. Microcavity sizes and shapes were designed to capture cancer cells through
23
application of negative pressure. This system enables efficient recovery of circulating tumor
24
cells. Furthermore, cancer cells can be rapidly recovered from the microcavity array by
25
hydrogel encapsulation for subsequent examination [13] by whole genome amplification and
8].
A microfluidic
pipette
array device
equipped
with
128
AC C
EP
TE D
[7,
M AN U
SC
RI PT
1
ACCEPTED MANUSCRIPT genetic analysis at the single-cell level.
27
In this study, we used a cell entrapment device consisting of a microcavity array was used to
28
analyze the deformability of MCF-10 human breast epithelial and MCF-7 human breast
29
cancer cells. Cell morphology was evaluated at various filtration pressures by confocal laser
30
scanning microscopy. We found that the normal and cancer cell lines could be distinguished
31
based on the degree of cell membrane extension induced by filtration pressure. The utility of
32
the microcavity array for assessing nucleus deformability was also investigated.
RI PT
26
SC
33 Material and methods
35
Cell culture
36
MCF-7 human breast cancer cells were cultured in Eagle’s minimal essential medium (MP
37
Bio, Santa Ana, CA, USA) supplemented with 1 mM sodium pyruvate, 10 µg/ml insulin, 1.5
38
mg/ml
39
penicillin-streptomycin. MCF-10 non-malignant human breast epithelial cells were cultured
40
in Dulbecco’s modified Eagle’s medium (Gibco, Grand Island, NY, USA) supplemented with
41
20 ng/ml epidermal growth factor, 0.5 µg/ml hydrocortisone, 10 µg/ml insulin, 5% (v/v) calf
42
serum, and 1% (v/v) penicillin-streptomycin. Cultures were maintained at 37°C and 5% CO2
43
for approximately 1 week. Prior to each experiment, confluent cell cultures were washed with
44
phosphate-buffered saline (PBS, pH 7.4) followed by trypsinization and resuspension in PBS.
10%
(v/v)
fetal
bovine
serum,
and
1%
(v/v)
EP
TE D
bicarbonate,
AC C
45
sodium
M AN U
34
46
Fabrication of a microcavity array
47
A nickel microcavity array was fabricated by electroformation as previously described [14].
48
The fabricated microcavity array had 10,000 (100 × 100) pores with sizes of 3, 8, 11, 15, and
49
20 µm separated by a distance of 25 µm (Fig. 1A). The microfluidic device for measuring
50
cell deformability was constructed by laminating the layers of the nickel microcavity array,
ACCEPTED MANUSCRIPT with a frame-shaped 2 mm-thick polymethyl methacrylate layer as a base and a
52
poly(dimethylsiloxane) (PDMS) structure equipped with a microchannel on the underside.
53
Each layer was assembled with spacer tapes. The microchannel at the bottom of the device
54
was connected to a peristaltic pump that drew the sample solution through the device (Fig.
55
1B).
RI PT
51
57
AC C
EP
TE D
M AN U
SC
56
58
Figure 1. Cell entrapment device equipped with a microcavity array. (A) Scanning electron
59
micrograph of the microcavity array (pore sizes: 3 µm). Scale bar: 20 µm. (B) Schematic
60
image of the cell entrapment device.
61 62
ACCEPTED MANUSCRIPT Measurement of ∆P across the microcavity array
64
To measure the differential pressure across the microcavity array, another PDMS structure
65
with microchannels was attached to the top of the cell entrapment device shown in Figure 1B.
66
DTXPlus disposable blood pressure transducers (BD Biosciences, Franklin Lakes, NJ, USA)
67
were connected to the up- and downstream points of the device, and a 5-ml syringe was
68
connected further upstream of the channel. PBS or cell suspension was introduced into the
69
device via the syringe and was drawn through by applying negative pressure at a flow rate of
70
200 µl/min using a peristaltic pump connected to the microchannel at the bottom of the
71
device. The difference in pressure between two points (∆P) was calculated with PowerLab
72
(ADInstruments, Colorado Springs, CO, USA) and analyzed using Lab Chart & Scope
73
software (ADInstruments).
74
M AN U
SC
RI PT
63
Confocal laser scanning microscopy
76
Cultured cells were labeled with 5 µM CellTracker Green or CellTracker Orange for 30 min,
77
then collected by centrifugation at 400 × g for 4 min, washed three times with PBS, counted,
78
and re-suspended in PBS at a concentration of 1.6 × 104 cells/ml. Stained cell suspensions (2–
79
8 × 103 cells/250–500 µl) were introduced into the microfluidic device and negative pressure
80
was applied to the samples using a peristaltic pump connected to the vacuum line. A 400-µl
81
volume of PBS was added to cells trapped on the microcavity array at a flow rate of 200 µl
82
/min. Cell Tracker Green-stained MCF-7 or MCF-10 cells (8 × 103) or a mixture of the two
83
cell types (stained with Cell Tracker Green and Orange, respectively) were also introduced
84
onto the microcavity array. Trapped cells were observed with a confocal laser scanning
85
microscope (FV1000-D IX81; Olympus, Tokyo, Japan), and 3D images of the trapped cells
86
were acquired by imaging adjacent Z-axis optical sections separated by 0.2 µm with
87
excitation wavelengths of 488 and 543 nm for Cell Tracker Green and Orange, respectively.
AC C
EP
TE D
75
ACCEPTED MANUSCRIPT To visualize nuclei and the F-actin cytoskeleton, cells were stained with ethidium homodimer
89
(excitation wavelength: 528 nm; emission wavelength: 617 nm) (Invitrogen, Carlsbad, CA,
90
USA) and Alexa Fluor 488-conjugated phalloidin, respectively. Image conversion into 3D
91
and processing were accomplished using Volocity software (PerkinElmer), which was also
92
used to measure cell membrane extension length of individual cells trapped on the
93
microcavity array.
94
RI PT
88
Fluorescence microscopic observation of F-actin
96
Confluent MCF-7 and MCF-10 cell monolayers were fixed in formalin for 10 min. After
97
rinsing with PBS, cells were permeabilized with 0.1% Triton X-100 in PBS for 5 min and
98
washed again with PBS and blocked with 1% bovine serum albumin in PBS for 20−30 min.
99
F-actin was labeled with Alexa Fluor 488-conjugated phalloidin for 20 min. Cell nuclei were
100
stained with 10 µg/ml Hoechst 33342 with excitation and emission wavelengths of 350 and
101
461 nm, respectively) for 20 min. Images of stained cells were acquired using IN Cell
102
Analyzer 2000 with 340–380/440–480 nm filters for Alexa Fluor 488, and 460–500/510–560
103
nm filters for Hoechst.
EP
104
TE D
M AN U
SC
95
Results and discussion
106
Estimation of differential filtration pressure (∆P) and cell deformability at various cell
107
concentrations
108
Microcavity flow rates (200–5000 µl/min) and pore sizes (3–20 µm) were first evaluated to
109
establish the optimal conditions for cell recovery. A flow rate of < 200 µl/min and pore size <
110
8 µm resulted in complete recovery of MCF-7 cells. The number of cells that were applied
111
was less than the number of pores in the microcavity (1 × 104); we therefore used a maximum
112
of 8 × 103 cells (80% coverage) in this study.
AC C
105
ACCEPTED MANUSCRIPT The ∆P values of the 3 µm-microcavity array with different numbers of MCF-7 cells trapped
114
on the surface are shown in Table 1. ∆P increased as a function of cell number due to the
115
capping of microcavities by the cells. The morphology of MCF-7 cells trapped on the
116
microcavity array was observed by confocal laser scanning microscopy. Representative
117
three-dimensional (3D) images of cells stained with CellTracker Green are shown in Figure
118
2A and B. The cells formed protrusions at the bottom surface that were presumed to be
119
caused by the negative pressure applied from the underside of the array. We also performed
120
the experiment using a microcavity array with larger pores (8 µm) and found that there was
121
no deformation of MCF-7 cells even when 8 × 103 cells were introduced into the system (data
122
not shown). We therefore used the 3 µm-microcavity array in subsequent experiments.
M AN U
SC
RI PT
113
123 124 125
Table 1. ∆P of a 3 µm-pore microcavity array as a function of MCF-7 cell number
TE D
126
Number of introduced cells
Filtration pressure (kPa)
0
0.8 ± 0.1
EP
4 × 103
128
6 × 103
2.1 ± 0.6
8 × 103
3.7 ± 0.3
AC C
127
1.1 ± 0.2
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
129
Figure 2. Confocal laser scanning micrographs of MCF-7 cells trapped on the microcavity
131
array. (A) Cell array and (B) single cell. Cells were stained with CellTracker Green. (C)
132
Schematic illustration of a single cell trapped in a microcavity.
TE D
130
133
The extension length of cellular protrusions (Fig. 2C)—defined as the length from the lower
135
surface of the microcavity array to the top of the protruding cell—increased at higher ∆P in a
136
linear fashion (Fig. 3A, B). These results indicate that cell deformability can be estimated by
137
the extension length of individual cells when known numbers of cells are trapped on the
138
array.
AC C
139
EP
134
SC
RI PT
ACCEPTED MANUSCRIPT
140
Figure 3. Relationship between ∆P and extension length of MCF-7 cells trapped on the
142
microcavity array. (A) XZ-slice images and (B) extension length of cells at each ∆P. Scale
143
bar: 10 µm.
M AN U
141
144
Comparison of MCF-7 and MCF-10 cell deformability
146
MCF-7 cells are more deformable than non-tumorigenic MCF-10 cells [15]. To assess the
147
potential for distinguishing between normal and malignant cells using our cell deformability
148
assay, we analyzed the extension length of MCF-10 and MCF-7 cells (8 × 103 each) trapped
149
on microcavity arrays and stained with CellTracker Green by confocal microscopy (Fig. 4A,
150
B). The extension length of MCF-7 cells was 2-fold greater than that of MCF-10 cells (Table
151
2), suggesting that the two cell lines were distinguishable by cell deformability as estimated
152
by extension length. The higher standard deviation (SD) among MCF-7 cells indicated
153
greater variability in their deformability as compared to MCF-10 cells.
154
AC C
EP
TE D
145
SC
RI PT
ACCEPTED MANUSCRIPT
155
Figure 4. XZ-slice images of (A, C) MCF-7 and (B, D) MCF-10 cells trapped either
157
separately (A, B) or in a mixture (C, D) on the microcavity array. Scale bar: 10 µm.
M AN U
156
158
To confirm the utility of the microcavity array for evaluating cell deformability, a mixture of
160
MCF-7 and MCF-10 cells (8 × 103) stained with Cell Tracker Green and Cell Tracker Orange,
161
respectively, was applied to the array and analyzed as described above (Fig. 4C, D). The two
162
cell lines were also distinguishable under these conditions based solely on extension length,
163
which again showed greater variability in MCF-7 (Table 2).
AC C
EP
TE D
159
ACCEPTED MANUSCRIPT 164
Table 2. Extension lengths of MCF-7 and MCF-10 cells trapped on the microcavity array Cell line
Extension length (µm)
MCF-7
3.0 ± 0.6
MCF-10
1.5 ± 0.3
RI PT
2.5 ± 0.8 (MCF-7) MCF-7 & MCF-10
1.5 ± 0.3 (MCF-10)
Filtration pressure: 3.7 kPa
SC
Applied cell numbers: 8000 cells Value: Mean ± S. D.
M AN U
165 166
We found that up to 8 × 103 cells were trapped within 3 min using the microcavity array. It is
168
possible to enhance the performance by increasing the number of microcavities up to 105 [16].
169
Although 3D imaging by confocal microscopy required approximately 3 min for 102 cells, a
170
microscope with a microlens array that generates a multi-beam laser would drastically reduce
171
the imaging time by eliminating the scanning step. Thus, cell entrapment using the
172
microcavity array is a powerful tool for rapid evaluation of cancer cell deformability.
174
Deformability of the cell nucleus
175
Cell stiffness depends on the integrity of cytoskeletal actin. Filamentous (F-)actin is a major
176
component of the cytoskeleton that stabilizes the plasma membrane. The F-actin network was
177
clearly observed in MCF-10 but not MCF-7 cells (Fig. S1), as previously reported [15]. We
178
speculated that the difference in cell deformability between the two cell lines was due to
179
differences in F-actin expression, which also influences nuclear stiffness [17]. We therefore
180
examined the deformability of cell nuclei by confocal laser scanning microscopy (Fig. 5) and
AC C
173
EP
TE D
167
ACCEPTED MANUSCRIPT found that like the plasma membrane, nuclei were deformed when 8 × 103 cells were
182
introduced onto the microcavity array with a 3-µm pore size. These results indicate that the
183
deformability of the nucleus can serve as another means of distinguishing between normal
184
and cancer cells.
185
It is well recognized that change in the structure and organization of cytoskeleton causes
186
larger deformability in various cancers, such as bladder cells [18], prostate cells [19], ovarian
187
cells [20] and thyroid cells [21]. These changes are generally related to partial loss of actin
188
filament or disorganization of microtubules, resulting in the lower density of cellular scaffold.
189
Furthermore, recently, HER2 overexpression causes deformation of the cell membrane [22].
190
Thus, the determination of cell stiffness will enable a more effective detection and
191
identification of cancer cells.
AC C
EP
TE D
192
M AN U
SC
RI PT
181
M AN U
SC
RI PT
ACCEPTED MANUSCRIPT
193
Figure 5. (A) Confocal laser scanning micrographs of MCF-7 cells trapped on the
195
microcavity array. Nuclei were stained with Hoechst 33342 (red) and F-actin was labeled
196
with Alexa 488-conjugated antibody (green). (B) Schematic illustration of a single cell
197
trapped on a microcavity. Scale bar: 2.5 µm.
EP
TE D
194
AC C
198 199
Conclusions
200
In this study, a cell entrapment device consisting of a microcavity array that was originally
201
developed for cancer cell recovery and subsequent genetic analysis at the single-cell level
202
was used to analyze cell deformability. The extension length of cell protrusions could be used
203
to estimate the deformability of the plasma membrane and nucleus and thereby distinguish
204
between normal and cancer cells. Our system provides a tool for high-throughput analysis of
ACCEPTED MANUSCRIPT 205
cancer cell deformability that can improve our understanding of the mechanisms underlying
206
tumor cell malignancy.
207 208 References
210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246
[1] S. Suresh, Biomechanics and biophysics of cancer cells, Acta Biomater, 3 (2007) 413-438. [2] V. Swaminathan, K. Mythreye, E.T. O'Brien, A. Berchuck, G.C. Blobe, R. Superfine, Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines, Cancer research, 71 (2011) 5075-5080. [3] W. Xu, R. Mezencev, B. Kim, L. Wang, J. McDonald, T. Sulchek, Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells, PLoS One, 7 (2012) 4. [4] R.M. Hochmuth, Micropipette aspiration of living cells, J Biomech, 33 (2000) 15-22. [5] Y. Li, C. Wen, H. Xie, A. Ye, Y. Yin, Mechanical property analysis of stored red blood cell using optical tweezers, Colloids Surf B Biointerfaces, 70 (2009) 169-173. [6] M.J. Rosenbluth, W.A. Lam, D.A. Fletcher, Force microscopy of nonadherent cells: a comparison of leukemia cell deformability, Biophys J, 90 (2006) 2994-3003. [7] A. Adamo, A. Sharei, L. Adamo, B. Lee, S. Mao, K.F. Jensen, Microfluidics-based assessment of cell deformability, Anal Chem, 84 (2012) 6438-6443. [8] S. Byun, S. Son, D. Amodei, N. Cermak, J. Shaw, J.H. Kang, V.C. Hecht, M.M. Winslow, T. Jacks, P. Mallick, S.R. Manalis, Characterizing deformability and surface friction of cancer cells, Proceedings of the National Academy of Sciences of the United States of America, 110 (2013) 7580-7585. [9] L.M. Lee, A.P. Liu, A microfluidic pipette array for mechanophenotyping of cancer cells and mechanical gating of mechanosensitive channels, Lab Chip, 15 (2015) 264-273. [10] M. Hosokawa, T. Hayata, Y. Fukuda, A. Arakaki, T. Yoshino, T. Tanaka, T. Matsunaga, Size-selective microcavity array for rapid and efficient detection of circulating tumor cells, Analytical chemistry, 82 (2010) 6629-6635. [11] M. Hosokawa, H. Kenmotsu, Y. Koh, T. Yoshino, T. Yoshikawa, T. Naito, T. Takahashi, H. Murakami, Y. Nakamura, A. Tsuya, T. Shukuya, A. Ono, H. Akamatsu, R. Watanabe, S. Ono, K. Mori, H. Kanbara, K. Yamaguchi, T. Tanaka, T. Matsunaga, N. Yamamoto, Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system, PloS one, 8 (2013) e67466. [12] M. Hosokawa, T. Yoshikawa, R. Negishi, T. Yoshino, Y. Koh, H. Kenmotsu, T. Naito, T. Takahashi, N. Yamamoto, Y. Kikuhara, H. Kanbara, T. Tanaka, K. Yamaguchi, T. Matsunaga, Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancer, Analytical chemistry, 85 (2013) 5692-5698.
AC C
EP
TE D
M AN U
SC
RI PT
209
ACCEPTED MANUSCRIPT
283 284
EP
TE D
M AN U
SC
RI PT
[13] T. Yoshino, T. Tanaka, S. Nakamura, R. Negishi, M. Hosokawa, T. Matsunaga, Simple and rapid manipulation of a single circulating tumor cell using visualization of hydrogel encapsulation towards single-cell whole-genome amplification, Anal Chem, (2016). [14] M. Hosokawa, T. Hayata, Y. Fukuda, A. Arakaki, T. Yoshino, T. Tanaka, T. Matsunaga, Size-selective microcavity array for rapid and efficient detection of circulating tumor cells, Analytical Chemistry, 82 (2010) 6629-6635. [15] J. Guck, S. Schinkinger, B. Lincoln, F. Wottawah, S. Ebert, M. Romeyke, D. Lenz, H.M. Erickson, R. Ananthakrishnan, D. Mitchell, J. Käs, S. Ulvick, C. Bilby, Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence, Biophysical Journal, 88 (2005) 3689-3698. [16] M. Hosokawa, M. Asami, S. Nakamura, T. Yoshino, N. Tsujimura, M. Takahashi, S. Nakasono, T. Tanaka, T. Matsunaga, Leukocyte counting from a small amount of whole blood using a size-controlled microcavity array, Biotechnology and bioengineering, 109 (2012) 2017-2024. [17] K. Yamauchi, M. Yang, P. Jiang, N. Yamamoto, M. Xu, Y. Amoh, K. Tsuji, M. Bouvet, H. Tsuchiya, K. Tomita, A.R. Moossa, R.M. Hoffman, Real-time in vivo dual-color imaging of intracapillary cancer cell and nucleus deformation and migration, Cancer Res, 65 (2005) 4246-4252. [18] M. Lekka, P. Laidler, D. Gil, J. Lekki, Z. Stachura, A.Z. Hrynkiewicz, Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy, Eur Biophys J, 28 (1999) 312-316. [19] E.C. Faria, N. Ma, E. Gazi, P. Gardner, M. Brown, N.W. Clarke, R.D. Snook, Measurement of elastic properties of prostate cancer cells using AFM, The Analyst, 133 (2008) 1498-1500. [20] W. Xu, R. Mezencev, B. Kim, L. Wang, J. McDonald, T. Sulchek, Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells, PloS one, 7 (2012) e46609. [21] M. Prabhune, G. Belge, A. Dotzauer, J. Bullerdiek, M. Radmacher, Comparison of mechanical properties of normal and malignant thyroid cells, Micron, 43 (2012) 1267-1272. [22] I. Chung, M. Reichelt, L. Shao, R.W. Akita, H. Koeppen, L. Rangell, G. Schaefer, I. Mellman, M.X. Sliwkowski, High cell-surface density of HER2 deforms cell membranes, Nature communications, 7 (2016) 12742.
AC C
247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282